Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Annals of Surgery|December 21, 2011
Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cellsManon J Pepels, Maaike de Boer, Peter Bult, et al.
The American Journal of Surgical Pathology|October 15, 2008
Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement?Carolien H M van Deurzen, Peter Bult, Maaike de Boer, et al.
Breast Cancer Research and Treatment|April 12, 2019
Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancerDominique J P van Uden, Marissa C van Maaren, Peter Bult, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognosticsMaschenka Ca Balkenhol, Francesco Ciompi, Żaneta Świderska-Chadaj, et al.
Plos One|June 5, 2012
Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancerJeroen F Vermeulen, Robert A H van de Ven, Cigdem Ercan, et al.
Nature Cell Biology|August 26, 2020
Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasionOlga Ilina, Pavlo G Gritsenko, Simon Syga, et al.
Annals of Surgical Oncology|September 30, 2006
Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patientsMarieke J Bolster, Peter Bult, René F M Schapers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Interobserver variability and the effect of education in the histopathological diagnosis of differentiated vulvar intraepithelial neoplasiaLoes C G van den Einden, Joanne A de Hullu, Leon F A G Massuger, et al.
Plos One|February 14, 2015
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patientsSandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
NPJ Breast Cancer|November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancerCaner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
Pageof 9